Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTPROTALIX BIOTHERAPEUTICS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PLX - FCF/OCF Historical data
| Date | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ -3.44M | 0% | $ -2.19M |
| 3/31/2025 | $ -1.56M | 0% | $ -572K |
| 12/31/2024 | $ 7.39M | 85.25% | $ 8.67M |
| 9/30/2024 | $ 7.17M | 86.66% | $ 8.28M |
| 6/30/2024 | $ -4.18M | 0% | $ -2.71M |
| 3/31/2024 | $ 4.37M | 74.45% | $ 5.87M |
| 12/31/2023 | $ -2.47M | 0% | $ -1.32M |
| 9/30/2023 | $ -8.64M | 0% | $ -7.52M |
| 6/30/2023 | $ -10.56M | 0% | $ -9.84M |
| 3/31/2023 | $ -22.82M | 0% | $ -22.17M |
Key Performance Insights, Last 5 Years
- PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) FCF/OCF stands at 0%.
- Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average FCF/OCF has been 82.12%.
- The median FCF/OCF for PROTALIX BIOTHERAPEUTICS INC during this period was 85.25%
- PROTALIX BIOTHERAPEUTICS INC reached its highest FCF/OCF over the past 5 years at 86.66%.
- The lowest FCF/OCF recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 74.45%
PROTALIX BIOTHERAPEUTICS INC's FCF/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF/OCF Benchmarks
Similar metrics to CF - Operations:
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow to Operating Cash Flow
[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].FCF / CF - Operations
(=) FCF/OCF FCF/OCF for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: FCF [ $ -22.65M ] / CF - Operations [ $ -22.24M ]
(=) FCF/OCF [ 0% ] PLX - Free Cash Flow to Operating Cash Flow, Last 5 years
74.45%
Minimum
Mar 31, 2024
86.66%
Maximum
Sep 30, 2024
82.12%
Average
85.25%
Median
FCF/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.45% with a standard deviation of 29.09%.
The following table provides additional summary stats:
FCF/OCF in the Market:
| filtered constituents | 2.51K |
|---|---|
| min | -23% |
| max | 171.58% |
| average | 71.45% |
| median | 80.76% |
| std | 29.09% |